References<!?show $^DOIziffer>
-
1
Shivananda S, Lennard-Jones J, Logan R. et al .
Incidence of inflammatory bowel disease across Europe: is there a difference between north and South? Results of the European collaborative study on inflammatory bowel disease.
Gut.
1996;
39
690-697
-
2
Eaden J A, Mayberry J F.
Colorectal cancer complicating ulcerative colitis: a review.
Am J Gastroenterol.
2000;
95
2710-2719
-
3
Eaden J A, Abrams K, Mayberry J F.
The true risk of colorectal cancer in ulcerative colitis: A meta-analysis.
Gut.
1999;
44 (suppl l)
T163(abstract)
-
4
Provenzale D, Kowdley K V, Arora S. et al .
Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis.
Gastroenterology.
1995;
109
1188-1196
-
5
Bansal P, Sonnenberg A.
Risk factors of colorectal cancer in inflammatory bowel disease.
Am J Gastroenterol.
1996;
91
44-48
-
6
Bernstein C N, Blanchard J F, Kliewer E, Wadja A.
Cancer risk in patients with inflammatory bowel disease.
Cancer.
2001;
91
854-862
-
7
Friedman S, Rubin P H, Bodian C, Harpaz N, Present D.
Screening and surveillance colonoscopy in chronic Crohn’s colitis.
Gastroenterology.
2001;
120
820-826
-
8
Farrell R J, Ang Y, Kileen P, O’Briain D SO, Kelleher D, Keeling P W. et al .
Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.
Gut.
2000;
47
514-519
-
9
Connell W R, Talbot I C, Harpaz N. et al .
Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.
Gut.
1994;
35
1419-1423
-
10
Odze R D.
Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological and molecular review.
Am J Gastroenterol.
1999;
94
1746-1750
-
11
Kiesslich R, Fritsch J, Holtmann M, Koehler H H, Stolte M, Kanzler S. et al .
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.
Gastroenterology.
2003;
124
880-888
-
12
Matsumoto T, Nakamura S, Jo Y, Yao T, Iida M.
Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis.
Am J Gastroenterol.
2003;
98
1827-1833
-
13
Connell W R, Lennard-Jones J E, Williams C B. et al .
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.
Gastroenterology.
1994;
107
934-944
-
14
Choi P M, Nugent F W, Schoetz D J. et al .
Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.
Gastroenterology.
1993;
105
418-424
-
15
Engelsgjerd M, Farraye F A, Odze R D.
Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.
Gastroenterology.
1999;
117
1288-1294
-
16
Delco F, Sonnenberg A.
A decision analysis of surveillance for colorectal cancer in ulcerative colitis.
Gut.
2000;
46
500-506
-
17
Provenzale D, Wong J, Onken J E, Lipscomb J.
Performing a cost-effectiveness analysis: surveillance of patients with ulceratuve colitis. L.
Am J Gastroenterol.
1998;
93
872-880
Marc Barthet
Department of Gastroenterology · Hôpital Nord, Chemin des Bourrely ·
13915 Marseille cedex 20
Phone: 04 91 96 87 37
Fax: 04 91 96 13 11
Email: mbarthet@mail.ap-hm.fr
